Developmental toxicity of the HIV-protease inhibitor indinavir in rats
β Scribed by Riecke, Kai ;Schulz, Thomas G. ;Shakibaei, Mehdi ;Krause, Bernd ;Chahoud, Ibrahim ;Stahlmann, Ralf
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 570 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0040-3709
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The pharmacokinetics of a series of novel cyclic, nonβpeptide inhibitors of HIV protease were studied in rats or dogs after intravenous and oral administration. Six symmetrically substituted cyclic urea compounds (XK234, XM311, XM320, XM321, XM323, and XM412), which effectively inhibite
JP-8 aviation fuel is being phased in as a replacement for both JP-4 and JP-5 jet fuels presently in use by the Air Force and Navy, respectively. At the present time, 11% of active-duty Air Force personnel are women of child-bearing age. This study was undertaken to determine the threat posed to the
Caprolactam was evaluated for developmental toxicity potential in both rats and rabbits by the oral route. In rats dosed on days 6-15 of gestation with 100,500 or 1000 mg/kg/day of caprolactam, the maternal survival rate was significantly lower in the high-dose group and implantation efficiencies we
The developmental effect of the topoisomerase inhibitor, etoposide, was investigated in pregnant rabbits given intravenous doses during early organogenesis. Does received 0, 0.25, 0.5, 1, or 2 mg/kg/day on days 7 through 9 of gestation. Fetal parameters were evaluated on day 28 of gestation. Live fe